| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 2,251,000 | 2,570,000 | 1,405,000 | 2,417,000 | | Cost of Revenue | 1,032,000 | 1,266,000 | (2,292,000) | 1,844,000 | | | Gross Profit | 1,219,000 | 1,304,000 | 3,697,000 | 573,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 832,000 | 779,000 | 2,970,000 | 71,000 | | Non Recurring | 14,000 | (130,000) | 156,000 | (64,000) | | Others | 216,000 | 226,000 | 216,000 | 249,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 157,000 | 429,000 | 355,000 | 317,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,000 | 12,000 | 21,000 | 21,000 | | Earnings Before Interest And Taxes | 170,000 | 441,000 | 376,000 | 338,000 | | Interest Expense | 122,000 | 124,000 | 131,000 | 131,000 | | Income Before Tax | 48,000 | 317,000 | 245,000 | 207,000 | | Income Tax Expense | 18,000 | 116,000 | 12,000 | 55,000 | | Minority Interest | (2,000) | (1,000) | (162,000) | 45,000 | | | | Net Income From Continuing Ops | 28,000 | 200,000 | 71,000 | 197,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 12,000 | 184,000 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 28,000 | 212,000 | 255,000 | 197,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $28,000 | $212,000 | $255,000 | $197,000 |
|
5.11% Nasdaq 
Income Statement
